GlassScriptPhysician profile
Jodi A Berendzen
NPI 1356509871
$3,002.40
in general payments reported to CMS, 2019-2025
33 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $301 · 2021: $545 · 2022: $509 · 2023: $367 · 2024: $372 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $453.25 | 2019-2022 | |
| Pfizer INC. | $431.77 | 2019-2025 | |
| Organon LLC | $312.33 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $188.88 | 2020-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $131.04 | 2019-2023 | Summit Doppler |
| Bayer Healthcare Pharmaceuticals INC. | $127.47 | 2019-2025 | |
| Dexcom, INC. | $121.85 | 2024-2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $118.23 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $107.83 | 2019-2024 | Gardasil, Gardasil 9 |
| Exeltis, USA INC. | $98.41 | 2022-2024 | Slynd |
| Daiichi Sankyo INC. | $95.41 | 2019-2023 | Injectafer |
| Hologic Sales and Service, LLC | $83.52 | 2019-2024 | Myosure Tissue Removal Device, Coolseal Generator, Novasure |
| Mayne Pharma Commercial LLC | $82.77 | 2021-2025 | |
| Allergan, INC. | $81.90 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $78.10 | 2023-2025 | Myfembree |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $60.96 | 2022-2024 | Veozah |
| Lsi Solutions INC | $49.78 | 2024 | Fornisee |
| Vertex Pharmaceuticals Incorporated | $46.95 | 2025 | |
| Amgen INC. | $43.85 | 2022-2025 | Evenity, Prolia |
| Radius Health, INC. | $39.45 | 2019-2025 | Tymlos |
| Avion Pharmaceuticals | $32.05 | 2020-2021 | |
| Duchesnay USA Incorporated | $31.78 | 2019 | |
| Millicent US INC | $21.37 | 2025 | Femlyv |
| Pharmacosmos Therapeutics INC. | $20.74 | 2023 | Monoferric |
| Boston Scientific Corporation | $20.70 | 2025 | Bulkamid |
| Myovant Sciences INC. | $19.30 | 2021 | |
| Sage Therapeutics, LLC | $15.84 | 2021 | |
| Minerva Surgical, INC | $15.73 | 2023 | |
| Aesculap, INC. | $15.51 | 2019 | |
| Medtronic, INC. | $15.39 | 2021 | |
| Agile Therapeutics, INC. | $14.50 | 2021 | |
| Kci USA, INC. | $13.99 | 2019 | |
| Dysis Medical, INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Berendzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.